Cargando…
Advances in the Management of Early-Stage Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with both inter- and intratumor heterogeneity, thought to result in a more aggressive course and worse outcomes. Neoadjuvant therapy (NAT) has become the preferred treatment modality of early-stage TNBC as it allows for the downstagi...
Autores principales: | Bhardwaj, Prarthna V., Wang, Yue, Brunk, Elizabeth, Spanheimer, Philip M., Abdou, Yara G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419523/ https://www.ncbi.nlm.nih.gov/pubmed/37569851 http://dx.doi.org/10.3390/ijms241512478 |
Ejemplares similares
-
Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center
por: Bhardwaj, Prarthna V., et al.
Publicado: (2023) -
Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors
por: Abdou, Yara, et al.
Publicado: (2022) -
Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023) -
Recent advances in managing triple-negative breast cancers
por: Bengala, Carmelo
Publicado: (2009) -
Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer
por: Jacobson, Anne
Publicado: (2022)